Clinical Research at Capital Cardiology Associates
Advancing cardiovascular care through innovation and compassion.
At Capital Cardiology Associates, we are dedicated to advancing cardiovascular care through innovative and compassionate approaches. A key part of this commitment involves our active participation in clinical research. Our physicians serve as principal investigators in groundbreaking clinical trials to explore the latest therapies, technologies, and treatment strategies for a wide range of cardiovascular conditions.
RECENT NEWS
Lipoprotein(a): The Hidden Heart Risk You Should Know About
At Capital Cardiology, we’re shedding light on a little-known but critically important cardiovascular risk factor: Lipoprotein(a), or Lp(a). Unlike traditional cholesterol markers, Lp(a) is inherited, rarely checked on routine blood panels, and doesn’t respond to diet or exercise. Yet, it plays a major role in premature heart disease and stroke — even in patients with otherwise normal cholesterol levels.
For many, a one-time Lp(a) blood test could provide answers to unexplained family history or early cardiac events. While no FDA-approved therapies currently exist to lower Lp(a), groundbreaking clinical trials are testing new treatments — including gene-silencing injections and once-daily oral pills that have shown reductions of up to 85% in early studies.
Capital Cardiology is proud to be part of this next frontier in cardiovascular prevention. Our research team is actively participating in trials that may change the way we manage heart disease for generations to come.
If you have a family history of early heart disease, unexplained cardiac events, or are simply interested in cutting-edge prevention strategies, talk to your cardiology team about Lp(a) testing. Learn more on our blog.
Meet the Clinical Research Principal Investigators
-
Dr. Rizwan Alimohammad
-
Dr. Augustin DeLago
-
Dr. Eugene Pashkovetsky
-
Dr. Scott Purga
-
Dr. Parag Shah
-
Dr. Lance Sullenberger
CCA Clinical Research Team
Dr. Christopher Chapman
Kaitlyn Walsh, NP
Shreya Shah, MPH, BDS
Eleonore Warren
Kynadi Henderson, MS
Capital Cardiology Associates actively participates in clinical trials to help advance the future of cardiovascular medicine and offer patients access to innovative treatments and therapies. By partnering with leading research organizations and pharmaceutical companies, CCA provides eligible patients the opportunity to participate in carefully monitored studies that explore new medications, devices, and procedures. These trials are conducted under strict safety protocols and overseen by experienced cardiologists and research staff, ensuring the highest standard of care. Participation is always voluntary and can offer early access to promising treatments that are not yet widely available.
FAQs
What is a Clinical Trial?
It's a research study where we test new therapies to see if they are safe and effective. By participating, you help us find better ways to treat or prevent a wide range of cardiovascular conditions.How are my safety and rights monitored?
The U.S. Food and Drug Administration (FDA) oversees all aspects of clinical research trials. Additionally, an independent committee, called an Institutional Review Board (IRB), ensures the study's ethics and safety. As a participant, you will have access to the IRB overseeing the research, as well as the physician and staff conducting the trial.What's Involved?
If you are a good fit for a study, we will explain everything:What the study is forThe possible risks and benefitsExactly what you'll need to do
Joining is always your choice, and you can stop at any time. If you participate, our team will give you close medical attention throughout the study.How Can I Learn More?
Just ask your doctor or nurse at your next appointment. They can tell you more and help you decide if a trial is right for you.Our ongoing trials can be found here: https://capitalcardiology.com/research-trials
Interested in participating in clinical research?